COVID-19 and Diabetes: Persistent Cardiovascular and Renal Risks in the Post-Pandemic Landscape

COVID-19 and Diabetes: Persistent Cardiovascular and Renal Risks in the Post-Pandemic Landscape

The Coronavirus Disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), disproportionately affects individuals with diabetes mellitus (DM) by exacerbating cardiovascular and renal complications. This increased risk is mediated through immune dysfunct...

Full description

Saved in:

Bibliographic Details
Main Authors:	Tzu-Shan Huang, Jo-Yen Chao, Ho-Hsiang Chang, Wei-Ren Lin, Wei-Hung Lin
Format:	Article
Language:	English
Published:	MDPI AG 2025-04-01
Series:	Life
Subjects:	diabetes mellitus COVID-19 cardiovascular disease acute kidney injury vaccination
Online Access:	https://www.mdpi.com/2075-1729/15/5/726
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diabetic kidney disease phenotypes and the risk of cardiovascular events: The Silesia Diabetes-Heart Project
by: Oliwia Janota-Sosińska, et al.
Published: (2025-07-01)

Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue
by: G. G. Arabidze, et al.
Published: (2024-06-01)

Impact of urinary tract infection requiring hospital admission on short-term, mid-term and long-term renal outcomes in adult CKD patients – A potentially modifiable factor for CKD progression
by: Deng-Chi Yang, et al.
Published: (2025-05-01)

Impact of Age and Ethnic Variability on Cardiovascular Risk in Chronic Kidney Disease Patients
by: Saif Ullah Shaikh, Afsheen Zehra, Areeb Arif Khan, Habib Saghir, Muhammad Saeed, Muhammad Faisal Fahim
Published: (2025-03-01)

Impact of Acute Kidney Injury, Co-Existing with and without Chronic Kidney Disease on the Short‐Term Adverse Outcomes Following Atherosclerotic Cardiovascular Disease Events in Patients with Diabetes
by: Chou CL, et al.
Published: (2025-04-01)

Joint association of the inflammatory marker and cardiovascular-kidney-metabolic syndrome stages with all-cause and cardiovascular disease mortality: a national prospective study
by: Yifei Cao, et al.
Published: (2025-01-01)

Why Diabetes Worsens Patient Prognosis: A Literature Review of Cardiovascular and Renal Complications
by: Magdalena Rafałowicz, et al.
Published: (2025-08-01)

Blood pressure control among Veterans with high cardiovascular disease risk
by: Aseel Zghayer, et al.
Published: (2025-03-01)

Life’s Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China
by: Mian Li, et al.
Published: (2025-05-01)

From Metabolic Syndrome to Cardio-Kidney-Metabolic Syndrome in the SIMETAP Study: Prevalence Rates of Metabolic Syndrome and Its Independent Associations with Cardio-Renal-Metabolic Disorders Other than Its Defining Criteria
by: Antonio Ruiz-García, et al.
Published: (2025-02-01)

Trends in the epidemiology of chronic kidney disease in Russian Federation according to the Federal Diabetes Register (2013–2016)
by: Minara S. Shamkhalova, et al.
Published: (2018-08-01)

Navigating the Evolving Landscape of Cardiovascular Training and Education
by: Nadeen N. Faza, et al.
Published: (2022-06-01)

PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN DIABETES MELLITUS: THE ROLE OF ASPIRIN
by: L. A. Strizhakov
Published: (2012-04-01)

The level of glycemia as a risk factor of cardiovascular diseases
by: Ashot Musaelovich Mkrtumyan
Published: (2010-09-01)

Cardiovascular Disease Assessment Prior to Kidney Transplantation
by: Angelina R. Edwards, et al.
Published: (2022-09-01)

Plasma Calmodulin as a Biomarker of Subclinical Cardiovascular Disease in Pediatric Chronic Kidney Disease
by: Hsin-Jung Lee, et al.
Published: (2025-05-01)

Association between Hemoglobin–albumin–lymphocyte–platelet score and all-cause or cardiovascular mortality in patients with diabetes or prediabetes: mediated effects of renal function
by: Pingping Zhao, et al.
Published: (2025-04-01)

Anticoagulation for Patients With Concomitant Atrial Fibrillation and End‐Stage Renal Disease: A Systematic Review and Network Meta‐Analysis
by: Ting‐Wei Kao, et al.
Published: (2024-04-01)

FOLLOWING THE PROBLEM OF PROGNOSIS AND COURSE OF CARDIOVASCULAR DISEASES AND DIABETES
by: B. U. Mardanov, et al.
Published: (2015-02-01)

Biomarkers of Adverse Cardiovascular Events in Kidney Disease
by: L. A. Kamyshnikova, et al.
Published: (2023-08-01)

State-Level Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in the United States, 2011 to 2023
by: Ryan Chang, BA, et al.
Published: (2025-06-01)

Associations of cardiovascular–kidney–metabolic syndrome stages with premature mortality and the role of social determinants of health
by: Ruixin Zhu, et al.
Published: (2025-04-01)

Cardiovascular-kidney-metabolic syndrome modifies smoking-related risk for cardiovascular diseases: findings from an observational cohort study in UK Biobank
by: Xinhui Liu, et al.
Published: (2025-05-01)

Study of Tryptase Activity and Selenium Concentration in Cardiovascular And Diabetic Patients
by: Nagham Qasim Kazim, et al.
Published: (2023-02-01)

Early-Life Prevention of Cardiovascular–Kidney–Metabolic Syndrome: The DOHaD Perspective on Resveratrol and Short-Chain Fatty Acids
by: Chien-Ning Hsu, et al.
Published: (2025-07-01)

The association of serum leptin levels with metabolic diseases
by: Jen-Pi Tsai
Published: (2017-01-01)

Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
by: Kyoung Hwa Ha, et al.
Published: (2025-02-01)

Cardiovascular Disease & Diabetes Statistics in Korea: Nationwide Data 2010 to 2019
by: Jin Hwa Kim, et al.
Published: (2024-11-01)

Association between the cardiometabolic index and cardiovascular disease risk in patients with cardiovascular-kidney-metabolic syndrome: a cohort study
by: De-Gang Mo, et al.
Published: (2025-07-01)

Diabetes Mellitus and Cardiovascular Disease: Exploring Epidemiology, Pathophysiology, and Treatment Strategies
by: Nawfal Hasan Siam, et al.
Published: (2024-12-01)

Framingham score in the evaluation of cardiovascular risk in diabetics
by: Mariana Costa Larré, et al.
Published: (2014-12-01)

Framingham score in the evaluation of cardiovascular risk in diabetics
by: Mariana Costa Larré, et al.
Published: (2014-12-01)

The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: evidence from two cohort studies
by: Mo-Yao Tan, et al.
Published: (2025-03-01)

Inhaling Poor Health: The Impact of Air Pollution on Cardiovascular Kidney Metabolic Syndrome
by: Haitham Khraishah, et al.
Published: (2024-11-01)

Association between atherogenic index of plasma with all-cause and cardiovascular mortality in individuals with Cardiovascular-Kidney-Metabolic syndrome
by: Qianrong Zheng, et al.
Published: (2025-04-01)

Nomenclature of renal involvement in diabetes mellitus: unify to manage diversity
by: María Marques, et al.
Published: (2025-03-01)

The relationship between blood urea nitrogen to serum albumin ratio and cardiovascular diseases, cardiovascular mortality, and all-cause mortality in patients with diabetes mellitus
by: Hongwei Zhu, et al.
Published: (2025-04-01)

Association of serum Klotho with the severity and mortality among adults with cardiovascular-kidney-metabolic syndrome
by: Jiao Tang, et al.
Published: (2024-12-01)

Visit‐to‐Visit Systolic Blood Pressure Variability Independently Predicts Cardiovascular Events in a Kidney Transplant Recipients' Cohort
by: Elisabetta Bussalino, et al.
Published: (2024-08-01)

Association between hypoglycemia unawareness and cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus: a prospective cohort study
by: Siqi Li, et al.
Published: (2025-06-01)